Copyright
©The Author(s) 2022.
World J Clin Cases. Jul 26, 2022; 10(21): 7502-7508
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7502
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7502
Figure 3 After chimeric antigen receptor T cells combined with programmed cell death protein-1 inhibitor treatment, positron emission tomography/computed tomography scan showed no viable lesions.
- Citation: Zhang CJ, Zhang JY, Li LJ, Xu NW. Refractory lymphoma treated with chimeric antigen receptor T cells combined with programmed cell death-1 inhibitor: A case report. World J Clin Cases 2022; 10(21): 7502-7508
- URL: https://www.wjgnet.com/2307-8960/full/v10/i21/7502.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i21.7502